UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Maxxim Medical, Inc.
---------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
---------------------------------------------------------------------------
(Title of Class of Securities)
42550P 10 0
---------------------------------------------------------------------------
(CUSIP Number)
Donald R. DePriest, 206 8th Street North, Columbus, Mississippi 39701
---------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
April 10, 1997
---------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Page 1 of 4
Check the following box if a fee is being paid with the statement [ ]. (A
fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the act (however,
see the Notes).
No Exhibits
SCHEDULE 13D
CUSIP No. 42550P 10 0 Page 2 of 4 Pages
------------
1 NAMES OF REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Donald R. DePriest
- ----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- ----------------------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------------------
4 SOURCE OF FUNDS*
- ----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- ----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
- ----------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF SHARES
BENEFICIALLY 26,664
OWNED BY -------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON
WITH -------------------------------------------------------
9 SOLE DISPOSITIVE POWER
26,664
-------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- ----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
26,664
---------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES* / /
- ----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.328%
- ----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- ----------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 2 of 4 Pages
Amendment Number 2
to
Schedule 13D
Item 5, Interest in Securities of the Issuer
------------------------------------
(a) - (b) DePriest currently owns 17,664 shares of Common Stock,
representing approximately 0.217% of the 8,128,827 shares of Common
Stock outstanding at November 3, 1996. DePriest also has the right to
acquire an additional 9,000 shares of Common Stock pursuant to currently
exercisable options, resulting in beneficial ownership of 26,664 shares
of Common Stock (0.328% of the Common Stock outstanding as of October
25, 1994).
DePriest disclaims beneficial ownership of shares of Common Stock
which are or may be deemed to be beneficially owned by or on behalf of
any person which is or may be deemed to be a member of a group with
DePriest.
(c) On January 15, 1997, DePriest sold 35,000 shares of the
Issuer's Common Stock on the open market for $13.2518 per share.
On March 26, 1997, DePriest sold 15,000 shares of the
Issuer's Common Stock on the open market for $14.9575 per share.
On March 27, 1997, DePriest sold 15,000 shares of the
Issuer's Common Stock on the open market for $14.6917 per share.
On April 1, 1997, DePriest sold 9,300 shares of the
Issuer's Common Stock on the open market for $14.50 per share.
On April 2, 1997, DePriest sold 1,000 shares of the
Issuer's Common Stock on the open market for $14.50 per share.
On April 7, 1997, DePriest sold 300 shares of the
Issuer's Common Stock on the open market for $14.50 per share.
On April 10, 1997, DePriest sold 359,400 shares of the
Issuer's Common Stock on the open market for $13.00 per share.
(d) DePriest has the sole right to receive and the power to direct
the receipt of dividends from, or the proceeds of, the sale of the
shares of Common Stock beneficially owned by him.
(e) DePriest ceased to be the beneficial owner of more than five
percent of the Common Stock on March 26, 1997.
THE NEXT PAGE IS THE SIGNATURE PAGE
Page 3 of 4 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
April 14, 1997 /s/DONALD R. DEPRIEST
-------------------- ------------------------
Date Donald R. DePriest
Page 4 of 4
